Skip to main content

Opaleye Management Inc.

Location
Boston, MA
Portfolio Value
Small $704,144,428
Diversification
Diversified
Filing Date
Global Rank
#2,155 / 7,976 ▲ 387
Top Industry
Biotechnology 47.2%
3Y Alpha vs SPY
+14.0%
Period ended 9 months ago
Filed Nov 14, 2025 · 7mo
23 quarters · since Mar 2020

Clone Performance

Jun 2023–Jun 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
+146.0%
SPY
+76.5%
Annualised alpha
+14.1%
Max drawdown
−42.1%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

42 positions · as of Sep 30, 2025 · Δ vs Jun 30, 2025
Top Position
26.7%
+1.3 pts
Top 5
55.9%
+1.3 pts
Top 10
73.3%
−4.2 pts
HHI
1,038
Dec 2022 → Sep 2025 · range 650 – 1,403
Diversified+26

Portfolio Trend

23 quarters · across all stocks

Sector Breakdown

As of Sep 30, 2025
Sector % Portfolio Value
Healthcare 100.0% $704,144,428

Last Quarter's Activity

Export CSV
Sep 30, 2025 vs Jun 30, 2025

Added To

Positions the filer increased
9 positions
Ticker Δ Shares Shares Value Open

Trimmed

Positions the filer reduced
11 positions
Ticker Δ Shares Shares Value Open

New Positions

Positions the filer opened this quarter
11 positions
Ticker Shares Value Open

Sold Out

Positions the filer fully exited
4 positions
Ticker Shares Value Open

Portfolio Positions

Export CSV View 13F filing
42 positions · $704,144,428 total · as of Sep 30, 2025
Ticker Company Shares Value (USD) % of Portfolio History